Symposia

INDUSTRY SYMPOSIA

AUDITORIUM / LEVEL -1

THURSDAY JANUARY 23

16.00 – 16.30

Symposium


17.30 – 18.00

Symposium


Moderator: Jean Pierre BECQUEMIN
Aortic arch FET treatment using Thoraflex™ hybrid
The surgical hybrid stent graft
-Epiflex French registry: rational and sequential analysis of early outcomes: T. Caus
-FET, multidisciplinary approach, Pre, Per and Post procedure: X. Chaufour
-FET, HEGP Paris results: H. Gautier

FRIDAY JANUARY 24

10.50 – 11.20

Symposium


11.40 – 12.10

Symposium


Bridging stents in FEVAR, what is the key to success
Bare or covered stents, when to use what for Iliac occlusive disease?
Covered stents as a problem solver for endovascular emergencies

14.50 – 15.20

Symposium


Paclitaxel: for whom and why do I use drug eluting technologies?
Moderator: Stephan HAULON
-DCB : studies, experience & recommendations, Raphaël COSCAS
-DES : studies, experience & recommendations, Yann GOUEFFIC
-DES: my experience since meta-analysis, Gilles GOYAULT

15.50 – 16.10

Symposium


SATURDAY JANUARY 25

09.50 – 10.20

Symposium


GORE® VIABAHN® endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Modérateur : Yann Goueffic
-Femoropopliteal bypasses with heparin-bonded PTFE are a durable treatment for long SFA-popliteal occlusions: when they are the best treatment and why, Nellie Della Schiava
-How to achieve good results with GORE® VIABAHN® endoprosthesis for treating complex femoropopliteal occlusive disease – clinical cases, Bertrand Saint Lebes
-Discussion animated by Yann Goueffic

11.30 – 12.00

Symposium


Published Lutonix safety data and the value of the Ultrascore device:
-Lutonix clinical program overview and published independent safety analysis results: Y. Goueffic
-How low pressure inflation with scoring technologies better preserves the vessel and increases revascularization success: R. Langhoff

Simultaneous translation:

Headphones will be available on request
(only if a valid ID is presented) when entering the room.

INDUSTRY SYMPOSIA

ROOM B / LEVEL 0

FRIDAY JANUARY 23

12.00

Symposium


First WavelinQ Patients in Bordeaux, Eric Ducasse
Covera stent “safe and effective” at treating failing arteriovenous access, Samed Awad